PATH:NYSEUiPath, Inc. Analysis

UiPath (PATH) is trading at roughly $10.86, marginally above its 20‑day SMA but still well below the 50‑day and 200‑day averages, indicating a bearish medium‑term bias. The RSI sits at 54, suggesting neutral momentum, while the MACD histogram has turned positive, offering a subtle bullish signal. Volatility remains elevated at over 54% for the past 30 days and a beta above 1.2 points to heightened sensitivity to market swings. Fundamentally, the company posts 13.6% revenue growth, an 83% gross margin, and a solid operating margin of 16.7%, underpinned by a cash pile of $1.47 bn against minimal debt. The DCF‑derived fair value of $23.55 implies roughly 24% upside from current levels, while the market’s “Extreme Greed” sentiment may be inflating short‑term buying pressure. Recent material news highlights the launch of on‑premise agentic AI for regulated sectors and a strategic integration with Databricks, expanding the addressable market and reinforcing the company’s competitive moat.
Analyst coverage remains cautious, with a median price target of $13 and a recent downgrade to $12, but the combination of strong cash generation, high margins, and emerging AI capabilities supports a longer‑run bullish view. The stock’s liquidity is robust, volume is rising, and the support zone near $9.20 offers a cushion against further downside, making the current price an attractive entry point for investors willing to navigate short‑term volatility.